Heptares Therapeutics discuss latest developments in GPCR structures and industry insights encompassing drug design
A new interview released with Ben Tehan,Principle Computational Chemist,Heptares Therapeutics about latest developments in GPCR structures and industry insights LONDON, UNITED KINGDOM, November 4, 2015 /EINPresswire.com/ -- In preparation for upcoming …